首页
400-620-6333
抗体
选项
-
Pinatuzumab (anti-CD22)关联靶标: CD22
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1639820-81-7 -
Epratuzumab (anti-CD22)关联靶标: CD22
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 205923-57-5 -
Inotuzumab (anti-CD22)关联靶标: CD22
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1660159-36-3 -
Ruplizumab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 220651-94-5 -
Toralizumab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 252662-47-8分子量: 148.43 (kD)SMILES: [Toralizumab] -
Pinatuzumab vedotin (anti-CD22)关联靶标: CD22
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
- 种属反应性: 人(Human), 大鼠(Rat), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAE
CAS号 : 1313706-14-7 -
Letolizumab (anti-TNFSF5)关联靶标: CD40LG
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; VHH-Fc; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: VHH-Fc
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1450981-87-9 -
CD154/CD40L Mouse mAb关联靶标: CD40LG
- 简短描述: mAb (5C8); Mouse anti Human/Monkey CD154/CD40L Antibody; in vitro blocking of CD40/CD40L signaling, in vivo blocking of CD40/CD40L signaling, IP, Flow; Unconjugated
- 种属反应性: 人(Human), 猴(Monkey)
- 亚型: Mouse IgG2a
- 宿主种属: 小鼠(Mouse)
- 克隆号: 5C8
- 偶联: Unconjugated
-
Frexalimab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 2515463-86-0SMILES: [Frexalimab] -
Moxetumomab (anti-CD22)关联靶标: CD22
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1622075-65-3 -
Dapirolizumab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
